Penserra Capital Management LLC Decreases Stock Holdings in Astera Labs, Inc. $ALAB

Penserra Capital Management LLC lowered its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 16.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,844 shares of the company’s stock after selling 9,712 shares during the period. Penserra Capital Management LLC’s holdings in Astera Labs were worth $4,506,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. EFG Asset Management North America Corp. purchased a new stake in Astera Labs during the 2nd quarter worth $2,369,000. First Horizon Advisors Inc. raised its position in Astera Labs by 12.4% in the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after purchasing an additional 108 shares during the period. Ellevest Inc. lifted its stake in shares of Astera Labs by 69.5% during the second quarter. Ellevest Inc. now owns 5,793 shares of the company’s stock worth $524,000 after purchasing an additional 2,376 shares in the last quarter. Next Capital Management LLC acquired a new position in shares of Astera Labs during the second quarter worth about $469,000. Finally, Bank of New York Mellon Corp boosted its position in shares of Astera Labs by 34.5% in the second quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock worth $47,208,000 after buying an additional 133,961 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the topic of several analyst reports. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Bank of America began coverage on shares of Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price objective for the company. Jefferies Financial Group lifted their price objective on shares of Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a research note on Tuesday, July 22nd. Susquehanna boosted their target price on shares of Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a research report on Thursday, August 7th. Finally, Wall Street Zen upgraded shares of Astera Labs from a “hold” rating to a “buy” rating in a research note on Monday, November 3rd. Thirteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $181.59.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Jack R. Lazar sold 22,500 shares of the stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the transaction, the director directly owned 97,351 shares in the company, valued at $17,369,365.42. This represents a 18.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jitendra Mohan sold 91,441 shares of the firm’s stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the transaction, the chief executive officer directly owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 534,480 shares of company stock valued at $97,000,380 over the last ninety days. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Stock Up 1.6%

ALAB stock opened at $165.49 on Monday. The stock’s 50 day moving average is $195.98 and its two-hundred day moving average is $141.10. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The company has a market capitalization of $27.95 billion, a PE ratio of 149.09, a P/E/G ratio of 3.09 and a beta of 1.38.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same period in the prior year, the business posted $0.23 EPS. The business’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.